The present invention relates to compounds of formula 1that are useful as an active ingredient of a medicament for preventive and/or therapeutic treatment of diseases caused by abnormal activation of CXCR3 chemokines.The invention relates furthermore to a process for the preparation of said compounds, to pharmaceutical compositions containing said compounds and to the novel intermediates used in the preparation of said compounds.本發明係關於式1之化合物其可用作醫藥品之活性成份供預防性及/或治療性治療由CXCR3趨化素不正常活化所造成的疾病。本發明另外係關於製備該化合物之方法、包含該化合物之組成物及用於製備該化合物之新穎的中間物。